Skip to main content

First Light Asset Management, LLC

13F filer · CIK 0001600004
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$1.65BU.S. long equity reported on 13F
Positions312 new · 6 closed
Net flow last quarter+$136MBuys minus sells
Top 10 positions weight60.7%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202631 positions
NEONeogenomics Inc$179M10.89%9.60%+26.2%Q4 2013
SIBNSI-BONE, Inc.$133M8.06%18.18%+51.8%Q2 2019
AXGNAxogen, Inc.$127M7.72%5.12%-31.3%Q3 2020
APGEApogee Therapeutics, Inc.$123M7.50%1.23%+61.3%Q4 2025
PVLAPalvella Therapeutics, Inc.$118M7.17%5.36%-21.3%Q3 2025
TWSTTwist Bioscience Corp$74.9M4.55%1.16%-17.2%Q4 2024
ELVNEnliven Therapeutics, Inc.$69.1M4.20%1.86%+574.1%Q1 2026
GHGuardant Health, Inc.$66.3M4.03%0.33%+57.5%Q4 2022
MASS908 Devices Inc.$54.7M3.32%16.51%+3.5%Q4 2020
AMLXAmylyx Pharmaceuticals, Inc.$54.3M3.30%2.71%-5.3%Q3 2025
WGSGeneDx Holdings Corp.$53.8M3.27%2.63%+222.7%Q1 2026
SLPSimulations Plus, Inc.$51.1M3.11%13.81%+6.1%Q3 2018
TNDMTandem Diabetes Care Inc$51.1M3.10%4.87%+157.4%Q1 2018
CRNXCrinetics Pharmaceuticals, Inc.$50.9M3.10%1.29%+24.9%Q4 2021
NPCENeuroPace Inc$45.5M2.76%8.35%+16.3%Q1 2025
EWTXEdgewise Therapeutics, Inc.$44.5M2.70%1.02%+9.3%Q4 2024
ANABAnaptysbio, Inc$39.3M2.39%2.00%-31.4%Q2 2023
TRVITrevi Therapeutics, Inc.$39.1M2.38%1.47%NewQ2 2026
SEPNSepterna, Inc.$32.3M1.96%2.11%+31.4%Q4 2025
TLSITriSalus Life Sciences, Inc.$29.8M1.81%10.66%+29.3%Q1 2026
TECXTectonic Therapeutic, Inc.$27.5M1.67%4.16%+23.6%Q3 2025
HCATHealth Catalyst, Inc.$25.5M1.55%17.17%-0.5%Q3 2019
BFLYButterfly Network, Inc.$22.2M1.35%Not reported-0.7%Q4 2024
ESTAEstablishment Labs Holdings Inc.$21.2M1.29%0.83%-19.9%Q1 2025
PCVXVaxcyte, Inc.$20.1M1.22%0.24%+143.4%Q1 2024
IRTCiRhythm Holdings, Inc.$19.9M1.21%0.51%-0.6%Q3 2023
OMCLOmnicell, Inc.$18.8M1.14%0.99%-7.7%Q4 2013
ATRCAtriCure, Inc.$15.9M0.97%1.12%-22.2%Q4 2013
KRMDKORU Medical Systems, Inc.$14.2M0.86%7.34%-10.1%Q4 2018
TCMDTactile Systems Technology Inc$13.8M0.84%2.04%Not reportedQ1 2023
RYTMRhythm Pharmaceuticals, Inc.$9.52M0.58%0.12%-1.6%Q3 2025
Q1 2026Reported May 15, 202635 positions
AXGNAxogen, Inc.$133M11.88%7.53%-23.5%Q3 2020
PVLAPalvella Therapeutics, Inc.$122M10.96%6.85%+38.3%Q3 2025
NEONeogenomics Inc$72.2M6.47%7.50%-3.0%Q4 2013
SIBNSI-BONE, Inc.$67.6M6.06%12.11%+6.4%Q2 2019
CNTACentessa Pharmaceuticals PLC$62M5.56%1.01%-31.5%Q1 2024
APGEApogee Therapeutics, Inc.$48.5M4.35%0.77%+102.4%Q4 2025
AMLXAmylyx Pharmaceuticals, Inc.$44.3M3.97%2.87%-4.9%Q3 2025
TWSTTwist Bioscience Corp$41.8M3.74%1.41%-23.0%Q4 2024
CRNXCrinetics Pharmaceuticals, Inc.$39.6M3.55%1.03%-8.8%Q4 2021
MASS908 Devices Inc.$37.2M3.33%16.23%+25.6%Q4 2020
NPCENeuroPace Inc$32.3M2.90%7.25%+82.3%Q1 2025
EWTXEdgewise Therapeutics, Inc.$31.6M2.83%0.93%-36.3%Q4 2024
ANABAnaptysbio, Inc$31.4M2.81%1.95%-12.5%Q2 2023
SLPSimulations Plus, Inc.$31.1M2.79%13.03%+33.7%Q3 2018
GHGuardant Health, Inc.$25.9M2.32%0.21%-4.9%Q4 2022
TNDMTandem Diabetes Care Inc$25.2M2.26%1.92%+20.7%Q1 2018
ATRCAtriCure, Inc.$20.8M1.87%1.44%-37.9%Q4 2013
TLSITriSalus Life Sciences, Inc.$20.3M1.82%8.25%NewQ1 2026
TECXTectonic Therapeutic, Inc.$20M1.79%3.44%Not reportedQ3 2025
IRTCiRhythm Holdings, Inc.$19.8M1.78%0.51%+9.3%Q3 2023
SEPNSepterna, Inc.$17.6M1.58%1.63%+18.1%Q4 2025
ESTAEstablishment Labs Holdings Inc.$17.5M1.57%1.05%-17.5%Q1 2025
HCATHealth Catalyst, Inc.$16.4M1.47%17.46%-0.3%Q3 2019
OMCLOmnicell, Inc.$16.4M1.47%1.08%Not reportedQ4 2013
KRMDKORU Medical Systems, Inc.$16.3M1.46%8.17%-10.5%Q4 2018
WGSGeneDx Holdings Corp.$15.6M1.40%0.82%NewQ1 2026
WVEWave Life Sciences, Inc.$13.4M1.20%0.96%-0.5%Q4 2025
VERAVera Therapeutics, Inc.$12.6M1.13%0.49%-63.9%Q1 2024
MDXGMimedx Group, Inc.$11.2M1.01%1.91%-6.5%Q4 2024
BFLYButterfly Network, Inc.$10.7M0.96%Not reported-5.4%Q4 2024
SGPSpyGlass Pharma, Inc.$9.72M0.87%1.12%NewQ1 2026
ORGOOrganogenesis Holdings Inc.$8.29M0.74%2.72%-9.4%Q2 2025
PCVXVaxcyte, Inc.$8.24M0.74%0.10%Not reportedQ1 2024
ELVNEnliven Therapeutics, Inc.$7.91M0.71%0.33%NewQ1 2026
RYTMRhythm Pharmaceuticals, Inc.$7.58M0.68%0.13%-70.5%Q3 2025
Q4 2025Reported Feb 17, 202632 positions
AXGNAxogen, Inc.$171M13.10%11.09%-9.9%Q3 2020
NEONeogenomics Inc$118M9.02%7.78%+1.1%Q4 2013
SIBNSI-BONE, Inc.$99.2M7.59%11.53%+162.4%Q2 2019
PVLAPalvella Therapeutics, Inc.$74.2M5.67%5.73%+31.0%Q3 2025
CNTACentessa Pharmaceuticals PLC$57M4.36%1.53%-37.3%Q1 2024
CRNXCrinetics Pharmaceuticals, Inc.$55.6M4.25%1.25%+26.8%Q4 2021
ATRCAtriCure, Inc.$46.5M3.56%2.36%+32.0%Q4 2013
VERAVera Therapeutics, Inc.$44M3.37%1.36%+71.5%Q1 2024
IRONDisc Medicine, Inc.$41.5M3.18%1.38%+126.3%Q3 2025
AMLXAmylyx Pharmaceuticals, Inc.$40.5M3.10%3.05%0.0%Q3 2025
EWTXEdgewise Therapeutics, Inc.$39.1M2.99%1.48%+11.2%Q4 2024
MDGLMadrigal Pharmaceuticals, Inc.$38.9M2.98%0.29%+479.2%Q3 2025
TWSTTwist Bioscience Corp$36.2M2.77%1.86%-4.5%Q4 2024
SLPSimulations Plus, Inc.$35.9M2.74%9.77%+156.5%Q3 2018
RYTMRhythm Pharmaceuticals, Inc.$31.7M2.42%0.44%+63.9%Q3 2025
WVEWave Life Sciences, Inc.$31.5M2.41%0.99%NewQ4 2025
ANABAnaptysbio, Inc$31.3M2.40%2.31%-34.7%Q2 2023
HCATHealth Catalyst, Inc.$30.9M2.36%17.93%-3.9%Q3 2019
GHGuardant Health, Inc.$30.1M2.30%0.23%+5.3%Q4 2022
IRTCiRhythm Holdings, Inc.$27.3M2.09%0.48%-0.8%Q3 2023
ESTAEstablishment Labs Holdings Inc.$27.2M2.08%1.27%-10.8%Q1 2025
MASS908 Devices Inc.$25.4M1.94%13.31%+92.6%Q4 2020
KRMDKORU Medical Systems, Inc.$24.5M1.87%9.08%-7.0%Q4 2018
TNDMTandem Diabetes Care Inc$23.9M1.83%1.60%Not reportedQ1 2018
APGEApogee Therapeutics, Inc.$21.5M1.64%0.42%NewQ4 2025
NPCENeuroPace Inc$20.8M1.59%4.02%-0.8%Q1 2025
MDXGMimedx Group, Inc.$20.6M1.57%2.05%-16.8%Q4 2024
ORGOOrganogenesis Holdings Inc.$20M1.53%3.04%-48.5%Q2 2025
SEPNSepterna, Inc.$17.3M1.32%1.39%NewQ4 2025
ABVXAbivax S.A.$12M0.91%0.11%-7.6%Q3 2025
BFLYButterfly Network, Inc.$10.7M0.82%Not reported+149.3%Q4 2024
DYNDyne Therapeutics, Inc.$3.04M0.23%0.09%Not reportedQ3 2020
Q3 2025Reported Nov 14, 202541 positions
AXGNAxogen, Inc.$104M9.76%12.59%+28.2%Q3 2020
PHLTPerformant Healthcare, Inc.$90.6M8.54%Not reported-11.0%Q3 2021
CNTACentessa Pharmaceuticals PLC$88.2M8.31%2.70%-15.3%Q1 2024
NEONeogenomics Inc$76.6M7.22%7.70%+45.0%Q4 2013
AMLXAmylyx Pharmaceuticals, Inc.$45.6M4.30%3.06%NewQ3 2025
CRNXCrinetics Pharmaceuticals, Inc.$39.2M3.70%1.00%+9.0%Q4 2021
HCATHealth Catalyst, Inc.$38.3M3.61%19.03%+9.9%Q3 2019
PVLAPalvella Therapeutics, Inc.$33.9M3.20%4.88%NewQ3 2025
TWSTTwist Bioscience Corp$33.6M3.17%1.97%+26.4%Q4 2024
LENZLENZ Therapeutics, Inc.$32.3M3.04%2.42%NewQ3 2025
ORGOOrganogenesis Holdings Inc.$31.6M2.98%5.91%+10.6%Q2 2025
ATRCAtriCure, Inc.$31.4M2.96%1.79%-12.3%Q4 2013
ANABAnaptysbio, Inc$30.3M2.86%3.59%-72.0%Q2 2023
SIBNSI-BONE, Inc.$28.2M2.66%4.43%+9.5%Q2 2019
CDTXCidara Therapeutics, Inc.$28M2.64%1.00%+62.0%Q2 2025
IRTCiRhythm Holdings, Inc.$26.7M2.51%0.48%-17.2%Q3 2023
MDXGMimedx Group, Inc.$25.5M2.40%2.47%+89.5%Q4 2024
EWTXEdgewise Therapeutics, Inc.$23M2.16%1.34%-17.5%Q4 2024
MASS908 Devices Inc.$22M2.07%6.95%+135.2%Q4 2020
MRUSMerus N.V.$21.1M1.99%0.30%NewQ3 2025
RYTMRhythm Pharmaceuticals, Inc.$18.2M1.72%0.27%NewQ3 2025
GHGuardant Health, Inc.$17.5M1.65%0.22%+117.3%Q4 2022
KRMDKORU Medical Systems, Inc.$17.3M1.63%9.78%-3.3%Q4 2018
ESTAEstablishment Labs Holdings Inc.$17.1M1.62%1.44%+0.3%Q1 2025
ADMAAdma Biologics, Inc.$15.7M1.48%0.45%+12.3%Q2 2025
IRONDisc Medicine, Inc.$15.3M1.44%0.66%NewQ3 2025
VERAVera Therapeutics, Inc.$14.7M1.39%0.79%-9.9%Q1 2024
NPCENeuroPace Inc$14M1.32%4.09%-1.5%Q1 2025
CAICaris Life Sciences, Inc.$11.9M1.12%0.14%-8.8%Q2 2025
SLPSimulations Plus, Inc.$11.6M1.09%3.81%+115.0%Q3 2018
RAREUltragenyx Pharmaceutical Inc.$8.59M0.81%0.30%-47.9%Q2 2019
ABVXAbivax S.A.$8.15M0.77%0.15%NewQ3 2025
SENSSenseonics Holdings, Inc.$7.85M0.74%44.12%-49.6%Q4 2024
RGENRepligen Corp$5.54M0.52%0.07%-5.7%Q3 2024
GPCRStructure Therapeutics Inc.$5.53M0.52%0.11%+61.5%Q3 2023
MDGLMadrigal Pharmaceuticals, Inc.$5.29M0.50%0.05%NewQ3 2025
EVHEvolent Health, Inc.$4.61M0.43%0.46%-26.2%Q4 2023
ALHCAlignment Healthcare, Inc.$3.54M0.33%0.10%-47.1%Q1 2025
RDNTRadNet, Inc.$3.22M0.30%0.05%-38.5%Q2 2025
TECXTectonic Therapeutic, Inc.$3.18M0.30%1.08%NewQ3 2025
BFLYButterfly Network, Inc.$2.18M0.21%Not reported-79.4%Q4 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.